Susanne Gebhard Selected Research

Breast Neoplasms (Breast Cancer)

1/2023	Effects of intermittent fasting on quality of life tolerance of chemotherapy in patients with gynecological cancers: study protocol of a randomized-controlled multi-center trial.
1/2021	Gene Expression-Based Prediction of Neoadjuvant Chemotherapy Response in Early Breast Cancer: Results of the Prospective Multicenter EXPRESSION Trial.
12/2014	Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.
11/2012	Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients.
5/2012	A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors.
1/2012	Immunoglobulin kappa C predicts overall survival in node-negative breast cancer.
2/2011	Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer.
1/2010	ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer.
9/2008	Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susanne Gebhard Research Topics

Disease

10	Neoplasms (Cancer) 01/2023 - 11/2003
9	Breast Neoplasms (Breast Cancer) 01/2023 - 09/2008
5	Neoplasm Metastasis (Metastasis) 12/2014 - 01/2010
3	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 11/2003
2	Carcinoma (Carcinomatosis) 11/2012 - 01/2012
1	Infections 04/2024
1	Endometrial Neoplasms (Endometrial Cancer) 01/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023
1	Chronic Disease (Chronic Diseases) 01/2023
1	Fallopian Tube Neoplasms 01/2023
1	Fatigue 01/2023
1	Pathologic Complete Response 01/2021
1	Residual Neoplasm 01/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2017
1	Shock 01/2016
1	Starvation 05/2010
1	Triple Negative Breast Neoplasms 09/2008

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2016 - 05/2010
3	Estrogen ReceptorsIBA 12/2014 - 01/2012
2	Phenobarbital (Luminal)FDA Link 01/2021 - 01/2012
2	AnthracyclinesIBA 01/2021 - 05/2012
2	Progesterone Receptors (Progesterone Receptor)IBA 12/2014 - 01/2012
2	RNA (Ribonucleic Acid)IBA 05/2012 - 02/2011
2	Immunoglobulins (Immunoglobulin)IBA 05/2012 - 01/2012
2	Epithelial Cell Adhesion MoleculeIBA 02/2011 - 09/2008
1	Daptomycin FDA Link 04/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2024
1	taxaneIBA 01/2021
1	InterferonsIBA 01/2019
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 08/2017
1	tocilizumab (atlizumab)FDA Link 08/2017
1	Interleukin-6 (Interleukin 6)IBA 08/2017
1	Sorafenib (BAY 43-9006)FDA Link 08/2017
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	Messenger RNA (mRNA)IBA 12/2014
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2014
1	ProstaglandinsIBA 12/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2014
1	Growth Factor ReceptorsIBA 12/2014
1	Aurora Kinase AIBA 11/2012
1	ParaffinIBA 05/2012
1	human ERBB2 proteinIBA 01/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Superoxide DismutaseIBA 05/2010
1	ManganeseIBA 05/2010
1	Heme (Haem)IBA 05/2010
1	DNA (Deoxyribonucleic Acid)IBA 05/2010
1	CatalaseIBA 05/2010
1	Carotenoids (Carotene)IBA 05/2010
1	isorenierateneIBA 05/2010
1	ClusterinIBA 01/2010
1	Hormones (Hormone)IBA 09/2008
1	4-epianhydrotetracycline (anhydrotetracycline)IBA 05/2006
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2003
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 11/2003
1	Therapeutic UsesIBA 11/2003
1	Tetracycline (Achromycin)FDA LinkGeneric 11/2003
1	Caspase 3 (Caspase-3)IBA 11/2003
1	Ki-67 Antigen (Ki 67 Antigen)IBA 11/2003

Therapy/Procedure

8	Therapeutics 01/2023 - 11/2003
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2019
2	Neoadjuvant Therapy 01/2021 - 05/2012
1	Immunotherapy 09/2008
1	Subcutaneous Injections 11/2003